James H. Warram

Joslin Diabetes Center

Papers

1

Total Citations

41

H-Index

1

About

James H. Warram is a distinguished epidemiologist and diabetes researcher whose work has fundamentally shaped our understanding of diabetic kidney disease. His research focuses on the natural history, risk factors, and biomarkers of diabetic nephropathy, particularly in type 1 diabetes. Warram’s major contributions include pioneering the identification of plasma kininogen and its fragments as early biomarkers of progressive renal decline—a discovery that opened new avenues for predicting and monitoring kidney disease before irreversible damage occurs. His landmark 2013 study on this topic, which has garnered 41 citations, exemplifies his ability to translate complex molecular findings into clinically actionable insights. Beyond this, Warram’s work has helped establish the critical role of genetic and environmental factors in the progression of diabetic complications, influencing international guidelines for patient screening and treatment. His research, often conducted in collaboration with the Joslin Diabetes Center, has been cited extensively, reflecting its lasting impact on both clinical practice and basic science. For students and researchers, Warram’s career demonstrates how rigorous epidemiology can bridge the gap between bench and bedside, offering hope for earlier intervention in devastating chronic diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes
41 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Joslin Diabetes Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago